Overview
Status
Active
Registry date
2012-09-25
Share capital
50,000.00 PLN
Registered address
ul. Cybernetyki 19B/331, 02-677 Warszawa, Poland
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 76 days for 2021).
- 202526/03/2026
- 202408/05/2025
- 202316/04/2024
- 202218/07/2023
- 202129/09/2022
- 202008/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 25.99mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 1.67mMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 22.47mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 12.61mMedianUSD 609.79kAverageUSD 11.85m
Industry
- Management consultancy activities (70.2)
Authorized Representatives
Aleksandra Brehova – Attorney-in-fact (sole)
Jevgenijs Brehovs – President of the Management Board
Manner of representation
Each member of the management board has the right to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksandra Brehovaage 38 | 250 | $3,376.55 | 25% |
Larisa Brehovaage 63 | 750 | $10,129.66 | 75% |
Larisa Brehova and Aleksandra Brehova hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Genetykalabsp. z o.o. | 1,080.50 USD | 80% |
Bank accounts
Registered as a VAT taxpayer on 2012-10-12.
62 1240 1040 1111 0011 1493 1349
92 1240 1040 1787 0011 1493 1541
45 1090 1883 0000 0001 6059 4123
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 213.5KPLN 213,484 |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-23 | Address change (Ul. Cybernetyki 19b/323, 02-677, Warszawa → Ul. Cybernetyki 19b/331, 02-677, Warszawa) | |
| 2024-02-19 | Share capital increase (5,000.00 PLN → 50,000.00 PLN) | |
| 2022-05-30 | Address change (Nowogrodzka 50/515, 00-695, Warszawa → Ul. Cybernetyki 19b/323, 02-677, Warszawa) | |
| 2021-07-19 | PKD change (Removed: 46.52.Z; Added: 46, 46.46.Z) | |
| 2016-08-22 | PKD change (Removed: 25 codes; Added: 1 code) |
FAQ
The main business activity of Limarr Enterprise focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 25, 2012.
The headquarters is located at: ul. Cybernetyki 19B, 02-677 Warszawa.
The management board consists of: Jevgenijs Brehovs (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $25,986,459, representing an increase of 26.7% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $1,673,468, meaning the company increased its profit by 69.5%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $20,337,544 in 2025, representing 91% of all operating expenses.
Last updated: 2026-07-08